Literature DB >> 3121251

Gossypol in the treatment of endometriosis and uterine myoma.

M L Han1, Y F Wang, M Y Tang, Q S Ge, L F Zhou, P D Zhu, Y T Sun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121251

Source DB:  PubMed          Journal:  Contrib Gynecol Obstet        ISSN: 0304-4246


× No keyword cloud information.
  6 in total

Review 1.  An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease.

Authors:  D Wu
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

2.  Gossypol treatment of recurrent adult malignant gliomas.

Authors:  P Bushunow; M M Reidenberg; J Wasenko; J Winfield; B Lorenzo; S Lemke; B Himpler; R Corona; T Coyle
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Involvement of Bcl-2, Src, and ERα in gossypol-mediated growth inhibition and apoptosis in human uterine leiomyoma and myometrial cells.

Authors:  Yan ZHU; Shu-wu XIE; Jian-feng ZHANG; Ting-ting ZHANG; Jie-yun ZHOU; Yang CAO; Lin CAO
Journal:  Acta Pharmacol Sin       Date:  2010-11-22       Impact factor: 6.150

4.  Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system.

Authors:  Liqian Ci; Zhigang Huang; Yu Liu; Zhepeng Liu; Gang Wei; Weiyue Lu
Journal:  Acta Pharm Sin B       Date:  2017-05-03       Impact factor: 11.413

Review 5.  A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.

Authors:  Hailemeleak Regassa; Anuradha Sourirajan; Vikas Kumar; Sadanand Pandey; Deepak Kumar; Kamal Dev
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

6.  Gossypol toxicity from cottonseed products.

Authors:  Ivana Cristina N Gadelha; Nayanna Brunna S Fonseca; Silvia Catarina S Oloris; Marília M Melo; Benito Soto-Blanco
Journal:  ScientificWorldJournal       Date:  2014-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.